Drug Trial Radar · NCT05013632
COVID-19 International Drug Pregnancy Registry
Last checked: Nov 19, 2026Latest source record: Sep 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,000
Planned (sponsor's estimate)
Start
Dec 1, 2021
Primary completion
Sep 30, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- PregistryIndustry
- Sponsor type
- Industry
- First posted
- Aug 19, 2021
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the COVID-19 International Drug Pregnancy Registry (COVID-PR) is to evaluate obstetric, neonatal, and infant outcomes among women treated with monoclonal antibodies or antiviral drugs indicated for mild, moderate, or severe COVID-19 from the first day of the last menstrual period (LMP) to end of pregnancy. For monoclonal antibodies, the exposure period also includes 90 days prior to the first day of the LMP.
Conditions
- Covid19
Interventions
Antiviral AgentsDrug
Antiviral medications indicated for the treatment of mild to severe COVID-19
Monoclonal antibodyDrug
Monoclonal antibodies indicated for the treatment of mild to severe COVID-19
Primary outcomes
What the sponsor says the trial is designed to measure.
- Obstetric outcomesTime frame: 1 year
- Neonatal outcomesTime frame: 1 year
- Infant weightTime frame: 1 year
- Infant developmental milestonesTime frame: 1 year
- Infant heightTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pregistry
Los Angeles, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.